Drug Type Biological products |
Synonyms |
Target |
Mechanism SGSH stimulants(N-sulphoglucosamine sulphohydrolase stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mucopolysaccharidosis III | Preclinical | US | 22 Mar 2022 |